Results 11 to 20 of about 103,759 (240)

European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome

European Journal of Neurology, 2023
Guillain–Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary greatly in presentation and severity. Besides weakness and sensory disturbances, patients may have cranial nerve involvement, respiratory insufficiency, autonomic ...
Pieter A. Doorn, P. V. D. Van den Bergh, R. Hadden, B. Avau, Patrik Vankrunkelsven, S. Attarian, Patricia H. Blomkwist‐Markens, D. Cornblath, H. Goedee, T. Harbo, B. C. Jacobs, Susumu Kusunoki, H. Lehmann, Richard A. Lewis, Michael P. Lunn, E. Nobile‐Orazio, L. Querol, Y. A. Rajabally, T. Umapathi, Haluk A. Topaloglu, Hugh J. Willison   +20 more
semanticscholar   +1 more source

Dynamics of Nerve Conduction Studies in Patients With Guillain-Barré Syndrome. [PDF]

Muscle Nerve
ABSTRACT Introduction/Aims The value of electrodiagnostic subtyping of Guillain–Barré syndrome (GBS) is still debated. This study aimed to determine the diagnostic yield, timing, and changes of the electrodiagnostic subtyping in patients with GBS in serial nerve conduction studies (NCS).
Arends S, de Koning L, Drenthen J, Zhu M, van den Bergh PYK, Hadden RM, Shahrizaila N, Reisin RC, Kuwabara S, Ajroud-Driss S, Antonini G, Balducci C, Barroso FA, Brannagan TH, Buermann J, Casasnovas C, Cavaletti G, Chao CC, Dillmann U, Dimachkie MM, Galassi G, Gutiérrez-Gutiérrez G, Harbo T, Hsieh ST, Islam B, Katzberg H, Kiers L, Mataluni G, Pardo J, Peréon Y, Rajabally YA, Stettner M, Verhamme C, Vytopil M, Waqar W, Cornblath DR, Jacobs BC, IGOS Consortium.   +37 more
europepmc   +2 more sources

Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates

International Journal of Molecular Sciences, 2022
Guillain–Barré syndrome (GBS) is a rare immune-mediated acute polyradiculo-neuropathy that typically develops after a previous gastrointestinal or respiratory infection. This narrative overview aims to summarise and discuss current knowledge and previous
J. Finsterer
semanticscholar   +1 more source

Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine

Cureus, 2021
Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications.
S. Waheed, A. Bayas, Fawzi Hindi, Zufe Rizvi, P. Espinosa   +4 more
semanticscholar   +1 more source

Guillain–Barré Syndrome Associated with SARS-CoV-2

New England Journal of Medicine, 2020
Guillain–Barre Syndrome with Covid-19 Five patients who had Guillain–Barre syndrome 5 to 10 days after the onset of Covid-19 are described.
G. Toscano, F. Palmerini, S. Ravaglia, L. Ruiz, P. Invernizzi, M. Cuzzoni, D. Franciotta, F. Baldanti, R. Daturi, P. Postorino, A. Cavallini, G. Micieli   +11 more
semanticscholar   +1 more source

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink

JAMA Network Open, 2022
Key Points Question Are COVID-19 vaccines associated with Guillain-Barré syndrome (GBS)? Findings In this cohort study of surveillance data from the Vaccine Safety Datalink that included 15.1 million doses of COVID-19 vaccines, the unadjusted incidence ...
K. Hanson, Kristin Goddard, N. Lewis, B. Fireman, T. Myers, N. Bakshi, Eric S. Weintraub, James G Donahue, Jennifer C. Nelson, Stanley Xu, J. Glanz, J. T. Williams, Jonathan D. Alpern, Nicola P. Klein   +13 more
semanticscholar   +1 more source

Prevalence, clinical characteristics and outcomes of Guillain−Barré syndrome spectrum associated with COVID‐19: A systematic review and meta‐analysis

European Journal of Neurology, 2021
Mounting evidence supports an association between Guillain−Barré syndrome spectrum (GBSs) and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection.
L. Palaiodimou, Maria-Ioanna Stefanou, A. Katsanos, P. Fragkou, M. Papadopoulou, Christos Moschovos, I. Michopoulos, P. Kokotis, Christos Bakirtzis, A. Naska, T. Vassilakopoulos, E. Chroni, S. Tsiodras, G. Tsivgoulis   +13 more
semanticscholar   +1 more source

Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States

JAMA Network Open, 2023
This cohort study investigates the association of Ad26.COV2.S, BNT162b2, and mRNA-1273 COVID-19 vaccination with rates of Guillain-Barré syndrome among US adults.
W. Abara, J. Gee, P. Marquez, Jared Woo, T. Myers, Allison DeSantis, Jane Baumblatt, E. Woo, Deborah Thompson, N. Nair, John R. Su, T. Shimabukuro, D. Shay   +12 more
semanticscholar   +1 more source

Guillain–Barré Syndrome Variant Occurring after SARS‐CoV‐2 Vaccination

Annals of Neurology, 2021
Although SARS‐CoV‐2 vaccines are very safe, we report 4 cases of the bifacial weakness with paresthesias variant of Guillain–Barré syndrome (GBS) occurring within 3 weeks of vaccination with the Oxford–AstraZeneca SARS‐CoV‐2 vaccine.
C. Allen, Shelby Ramsamy, A. Tarr, P. Tighe, W. Irving, R. Tanasescu, Jonathan Evans   +6 more
semanticscholar   +1 more source

Guillain Barre syndrome associated with COVID-19 infection: A case report

Journal of clinical neuroscience, 2020
Novel outbreak with coronavirus 2019 began since 31 December 2019. Coronaviruses can cause multiple systemic infections that respiratory complications are the most obvious symptoms. In this report, we describe the symptoms of Guillain Barre syndrome (GBS)
Z. Sedaghat, N. Karimi
semanticscholar   +1 more source